The IL-6 signaling in myeloid cells, such as neutrophils, is important for the generation and release of miR-223-enriched EVs, which may inhibit the progression of fibrosis in NASH-associated fibrosis (121, 122). Here, IL6 is linked to metabolic dysfunction-associated steatohepatitis.